Read More
Newsletter Signup | Join Community | Cancer Types
Precision Cancer Medicine Combination of Zejula and Keytruda Promising in Triple Negative Breast Cancer
MedMaven
Jul 22, 2019
Dec 14, 2019
by
ASCO Update of IMpassion130 clinical trial: Tecentriq improves outcomes of Triple Negative Breast Cancer
Jun 1, 2019
Neoadjuvant Keytruda, Tecentriq, and Sacituzumab Govitecan (IMMU-132) are promising TNBC treatment advances.
Cancer Connect
Feb 4, 2020
Dr. Bhuvaneswari Ramaswamy of the OSU Arthur G. James Cancer Hospital answers frequently asked questions about TNBC
Feb 1, 2020
Stay Current With Triple-Negative Breast Cancer Treatment Advances & Connect with Others
TraceyS
Feb 4, 2019
Iniparib Promising in Metastatic Triple-negative Breast Cancer
Aug 28, 2018
Obesity Linked with Triple-Negative Breast Cancer
Erbitux May Increase Response Rates in Metastatic Triple-Negative Breast Cancer.
Triple Negative Breast Cancer Linked with Higher Rate of Distant Metastases.
Aug 27, 2018
Jul 30, 2019
Is anyones doctor recommending treatment with a checkpoint inhibitor? These seem like they coul...
Oct 29, 2018
Interesting data published this week show HDC appears to benefit TNBC: https://mavendoctors…
